Abstract

BackgroundIdentifying intestinal node-negative gastric adenocarcinoma (INGA) patients with high risk of recurrence could help perceive benefit of adjuvant therapy for INGA patients following surgical resection. This study evaluated whether the computer-extracted image features of nuclear shapes, texture, orientation, and tumor architecture on digital images of hematoxylin and eosin stained tissue, could help to predict recurrence in INGA patients.MethodsA tissue microarrays cohort of 160 retrospectively INGA cases were digitally scanned, and randomly selected as training cohort (D1 = 60), validation cohort (D2 = 100 and D3 = 100, D2 and D3 are different tumor TMA spots from the same patient), accompanied with immunohistochemistry data cohort (D3′ = 100, a duplicate cohort of D3) and negative controls data cohort (D5 = 100, normal adjacent tissues). After nuclear segmentation by watershed-based method, 189 local nuclear features were captured on each TMA core and the top 5 features were selected by Wilcoxon rank sum test within D1. A morphometric-based image classifier (NGAHIC) was composed across the discriminative features and predicted the recurrence in INGA on D2. The intra-tumor heterogeneity was assessed on D3. Manual nuclear atypia grading was conducted on D1 and D2 by two pathologists. The expression of HER2 and Ki67 were detected by immunohistochemistry on D3 and D3′, respectively. The association between manual grading and INGA outcome was analysis.ResultsIndependent validation results showed the NGAHIC achieved an AUC of 0.76 for recurrence prediction. NGAHIC-positive patients had poorer overall survival (P = 0.017) by univariate survival analysis. Multivariate survival analysis, controlling for T-stage, histology stage, invasion depth, demonstrated NGAHIC-positive was a reproducible prognostic factor for poorer disease-specific survival (HR = 17.24, 95% CI 3.93–75.60, P < 0.001). In contrast, human grading was only prognostic for one reader on D2. Moreover, significant correlations were observed between NGAHIC-positive patients and positivity of HER2 and Ki67 labeling index.ConclusionsThe NGAHIC could provide precision oncology, personalized cancer management.

Highlights

  • Identifying intestinal node-negative gastric adenocarcinoma (INGA) patients with high risk of recur‐ rence could help perceive benefit of adjuvant therapy for INGA patients following surgical resection

  • Because intestinal node-negative gastric adenocarcinoma (INGA) patients have a good prognosis, it remains controversial whether adjuvant chemotherapy is needed for INGA patients after surgery

  • Nuclear atypia grade by human readers Since the histomorphometric features we investigate related to nuclear atypia, key predictors of prognosis in various cancers [2, 5, 6, 8,9,10,11,12,13,14,15, 18,19,20]

Read more

Summary

Introduction

Identifying intestinal node-negative gastric adenocarcinoma (INGA) patients with high risk of recur‐ rence could help perceive benefit of adjuvant therapy for INGA patients following surgical resection. The gastric cancer (GC) is a common gastrointestinal tumor with high mortality and the second leading cause of death in China [1]. For these cases, 80% are gastric adenocarcinoma (GA). There is controversy surrounding the benefit of adjuvant therapy for patients with resected stage IB, especially pT2N0. Guidelines from the European Society for Medical oncology (ESMO) suggest adjuvant therapy for all patients with resected stage IB disease, including those with pT2N0 tumors. While chemotherapy has many side effects, such as loss of hair, myelosuppression, damage to liver and kidney, and additional extensive medical burden, it is critical to distinguish recurrence in INGA patients perceived benefit of adjuvant chemoradiation after an R0 resection

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call